This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars
Trial details
- Registry ID
- NCT06774625
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third MolarsNCT06774625 | Latigo Biotherapeutics | Phase 2 | Completed | 2025-08-08Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |